Cargando…

Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022

Background: Stenotrophomonas maltophilia is an important cause of opportunistic healthcare-associated infections (HAIs) in critically ill patients and is difficult to treat due to intrinsic resistance to multiple antibiotic classes. During the COVID-19 pandemic, the CDC received anecdotal reports of...

Descripción completa

Detalles Bibliográficos
Autores principales: Keaton, Amelia, Fike, Lucy, Spicer, Kevin, Kallen, Alexander, Perkins, Kiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594243/
http://dx.doi.org/10.1017/ash.2023.352
_version_ 1785124604894773248
author Keaton, Amelia
Fike, Lucy
Spicer, Kevin
Kallen, Alexander
Perkins, Kiran
author_facet Keaton, Amelia
Fike, Lucy
Spicer, Kevin
Kallen, Alexander
Perkins, Kiran
author_sort Keaton, Amelia
collection PubMed
description Background: Stenotrophomonas maltophilia is an important cause of opportunistic healthcare-associated infections (HAIs) in critically ill patients and is difficult to treat due to intrinsic resistance to multiple antibiotic classes. During the COVID-19 pandemic, the CDC received anecdotal reports of increases in S. maltophilia respiratory infections. To further investigate these reports, we used a national electronic healthcare database to evaluate changes in S. maltophilia during the pandemic. Methods: Using the PINC-AI healthcare data (Premier Inc, Charlotte, NC) we identified all potential HAIs by calculating the total number of unique patients hospitalized during January 1, 2018, through December 31, 2021, who had any organism isolated on clinical culture obtained >3 days after admission. We calculated the proportion of patients with S. maltophilia detected in culture and stratified them by specimen source. To determine whether COVID-19 diagnosis influenced the proportion of patients diagnosed with S. maltophilia respiratory infections during the pandemic (January 1, 2020–December 31, 2021), we calculated the proportion of patients with S. maltophilia detected among those with any bacterial pathogen isolated from a respiratory culture >3 days after hospitalization. We stratified these results by presence or absence of concurrent COVID-19 diagnosis. Pearson χ(2) test was used to test for differences where appropriate. Results: Among hospitalized patients with any organism isolated from a clinical culture, the proportion with S. maltophilia detected was higher in 2021 (n = 2,554 of 118,029, 2.2%) than in 2018 (n = 2,063 of 155,624, 1.3%) p 3 days after hospital admission from 2018 to 2021. Most patient isolates were from respiratory specimens. A concurrent diagnosis of COVID-19 did not appear to increase the likelihood of respiratory S. maltophilia detection. The increases in S. maltophilia during the pandemic might be explained by challenges inherent to caring for increased numbers of higher-acuity patients during this time, including staffing shortages and changes to infection prevention practices. Additional exploration of these data, as well as data from other sources and from additional years, may help to elucidate this issue more fully. Disclosures: None
format Online
Article
Text
id pubmed-10594243
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-105942432023-10-25 Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022 Keaton, Amelia Fike, Lucy Spicer, Kevin Kallen, Alexander Perkins, Kiran Antimicrob Steward Healthc Epidemiol Outbreaks Background: Stenotrophomonas maltophilia is an important cause of opportunistic healthcare-associated infections (HAIs) in critically ill patients and is difficult to treat due to intrinsic resistance to multiple antibiotic classes. During the COVID-19 pandemic, the CDC received anecdotal reports of increases in S. maltophilia respiratory infections. To further investigate these reports, we used a national electronic healthcare database to evaluate changes in S. maltophilia during the pandemic. Methods: Using the PINC-AI healthcare data (Premier Inc, Charlotte, NC) we identified all potential HAIs by calculating the total number of unique patients hospitalized during January 1, 2018, through December 31, 2021, who had any organism isolated on clinical culture obtained >3 days after admission. We calculated the proportion of patients with S. maltophilia detected in culture and stratified them by specimen source. To determine whether COVID-19 diagnosis influenced the proportion of patients diagnosed with S. maltophilia respiratory infections during the pandemic (January 1, 2020–December 31, 2021), we calculated the proportion of patients with S. maltophilia detected among those with any bacterial pathogen isolated from a respiratory culture >3 days after hospitalization. We stratified these results by presence or absence of concurrent COVID-19 diagnosis. Pearson χ(2) test was used to test for differences where appropriate. Results: Among hospitalized patients with any organism isolated from a clinical culture, the proportion with S. maltophilia detected was higher in 2021 (n = 2,554 of 118,029, 2.2%) than in 2018 (n = 2,063 of 155,624, 1.3%) p 3 days after hospital admission from 2018 to 2021. Most patient isolates were from respiratory specimens. A concurrent diagnosis of COVID-19 did not appear to increase the likelihood of respiratory S. maltophilia detection. The increases in S. maltophilia during the pandemic might be explained by challenges inherent to caring for increased numbers of higher-acuity patients during this time, including staffing shortages and changes to infection prevention practices. Additional exploration of these data, as well as data from other sources and from additional years, may help to elucidate this issue more fully. Disclosures: None Cambridge University Press 2023-09-29 /pmc/articles/PMC10594243/ http://dx.doi.org/10.1017/ash.2023.352 Text en © The Society for Healthcare Epidemiology of America 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Outbreaks
Keaton, Amelia
Fike, Lucy
Spicer, Kevin
Kallen, Alexander
Perkins, Kiran
Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022
title Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022
title_full Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022
title_fullStr Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022
title_full_unstemmed Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022
title_short Healthcare-associated Stenotrophomonas maltophilia infections in the United States, 2018–2022
title_sort healthcare-associated stenotrophomonas maltophilia infections in the united states, 2018–2022
topic Outbreaks
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594243/
http://dx.doi.org/10.1017/ash.2023.352
work_keys_str_mv AT keatonamelia healthcareassociatedstenotrophomonasmaltophiliainfectionsintheunitedstates20182022
AT fikelucy healthcareassociatedstenotrophomonasmaltophiliainfectionsintheunitedstates20182022
AT spicerkevin healthcareassociatedstenotrophomonasmaltophiliainfectionsintheunitedstates20182022
AT kallenalexander healthcareassociatedstenotrophomonasmaltophiliainfectionsintheunitedstates20182022
AT perkinskiran healthcareassociatedstenotrophomonasmaltophiliainfectionsintheunitedstates20182022